Literature DB >> 2373025

Control of division and differentiation in oligodendrocyte-type-2 astrocyte progenitor cells.

M Noble1, S C Barnett, O Bögler, H Land, G Wolswijk, D Wren.   

Abstract

Oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells give rise to oligodendrocytes and type-2 astrocytes in cultures of rat optic nerve. These progenitors are one of the few cell types in which most aspects of proliferation and differentiation can be manipulated in a defined in vitro environment. When exposed to platelet-derived growth factor (PDGF), O-2A progenitors divide a limited number of times before clonally related cells differentiate into oligodendrocytes with a timing similar to that seen in vivo. In contrast, O-2A progenitors grown in the absence of mitogen do not divide but differentiate prematurely into oligodendrocytes, and progenitors exposed to appropriate inducing factors differentiate into type-2 astrocytes. O-2A progenitors can become immortalized through at least two different mechanisms. First, when O-2A progenitors are exposed to a combination of PDGF and basic fibroblast growth factor (bFGF) these cells undergo continuous self-renewal in the absence of differentiation. In contrast, the application of bFGF alone is associated with premature oligodendrocytic differentiation of dividing O-2A lineage cells. Thus, cooperation between growth factors can modulate O-2A progenitor self-renewal in a defined chemical environment by eliciting a novel programme of division and differentiation which cannot be predicted from the effects of either factor examined in isolation. A further mechanism which allows prolonged self-renewal in the O-2A lineage is the generation of a stem cell. O-2A progenitors isolated from optic nerves of perinatal rats also have the capacity to give rise to a population of cells called O-2Aadult progenitors, which differ from their perinatal counterparts in many characteristics. Most importantly, O-2Aadult progenitors have a slow cell cycle, divide and differentiate asymmetrically and appear to have the capacity for prolonged self-renewal. Thus, immortalization in this lineage can also be achieved by the generation of a cell with stem cell-like characteristics from a rapidly dividing progenitor population.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373025     DOI: 10.1002/9780470513927.ch14

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  6 in total

1.  Temperature-dependent regulation of PLP/DM20 and CNP gene expression in two conditionally-immortalized jimpy oligodendrocyte cell lines.

Authors:  E R Bongarzone; L M Foster; S Byravan; V Schonmann; A T Campagnoni
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

2.  PDGF-AA mediates B104CM-induced oligodendrocyte precursor cell differentiation of embryonic neural stem cells through Erk, PI3K, and p38 signaling.

Authors:  Jian-Guo Hu; Yan-Xia Wang; Hong-Ju Wang; Ming-Sheng Bao; Zhen-Huan Wang; Xin Ge; Feng-Chao Wang; Jian-Sheng Zhou; He-Zuo Lü
Journal:  J Mol Neurosci       Date:  2011-09-28       Impact factor: 3.444

3.  Control of oligodendrocyte generation and proliferation by Shp2 protein tyrosine phosphatase.

Authors:  Ying Zhu; Jinsil Park; Xuemei Hu; Kang Zheng; Hong Li; Qilin Cao; Gen-Sheng Feng; Mengsheng Qiu
Journal:  Glia       Date:  2010-09       Impact factor: 7.452

4.  PDGF in gliomas: more than just a growth factor?

Authors:  Nanna Lindberg; Eric C Holland
Journal:  Ups J Med Sci       Date:  2012-02-29       Impact factor: 2.384

5.  Schwann cells of the myelin-forming phenotype express neurofilament protein NF-M.

Authors:  B M Kelly; C S Gillespie; D L Sherman; P J Brophy
Journal:  J Cell Biol       Date:  1992-07       Impact factor: 10.539

6.  Kif3a deletion prevents primary cilia assembly on oligodendrocyte progenitor cells, reduces oligodendrogenesis and impairs fine motor function.

Authors:  Carlie L Cullen; Megan O'Rourke; Shannon J Beasley; Loic Auderset; Yilan Zhen; Renee E Pepper; Robert Gasperini; Kaylene M Young
Journal:  Glia       Date:  2020-12-24       Impact factor: 7.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.